|
|
EGRP’s Four Branches
Methods and Technologies Branch |
|
Mukesh Verma, Ph.D.
Branch Chief |
The Methods and Technologies Branch (MTB) focuses on methods
to address epidemiologic data collection, study design and analysis,
and to modify technological approaches developed in the context
of other research endeavors for use as biomarkers and methods to
understand cancer susceptibility.
MTB’s mission is to plan, develop, direct, coordinate, and
evaluate a comprehensive program of extramural research related
to epidemiologic methods to:
- address epidemiologic research issues and translate technological
approaches developed in the context of other research endeavors
to development of biomarkers of risk susceptibility and to
cancer epidemiologic settings
- translate paradigms and findings
from basic biological sciences into epidemiologic studies and
ensure that epidemiologic findings can be used to identify research
directions in the basic sciences
- improve epidemiologic study data
collection, study designs, and analysis
- assess the reliability
and validity of methods and technologies for use in epidemiologic
studies and ensure that these methods are sufficiently robust
to use in epidemiologic data collection settings
It also disseminates findings from the research supported by the
Branch to epidemiologists, the public, health care professionals,
scientists engaged in cancer control, and the public health community. |
Modifiable Risk Factors Branch |
|
Britt Reid, D.D.S., Ph.D.
Branch Chief |
The Modifiable Risk Factors Branch (MRFB) focuses on factors
that may be modifiable, such as diet and nutrition, alcohol, physical
activity and energy balance, tobacco, infectious diseases, physical
and chemical agents, and medical exposures including medications
and treatments.
MRFB’s mission is to plan, develop, direct, coordinate,
and evaluate:
- a comprehensive program of extramural epidemiologic research
in the etiology of cancer in human populations relating to
factors that may be modifiable such as nutrition, physical
activity and energy balance, infectious diseases, and physical
and chemical agents
- a program of extramural epidemiologic research to study differences
in cancer susceptibility and risk in individuals and populations
and the multiple environmental and genetic factors that jointly
contribute to cancer, with the ultimate goal of elucidating the
etiology of cancer
- a program of extramural epidemiologic research
to evaluate the association of and magnitude of cancer risk associated
with biomarkers of exposure, biologically effective dose, and
early damage
- research resources, infrastructures, and consortia
with a focus on modifiable risk factors to facilitate and maximize
the scientific potential of cancer epidemiology research
Its mission is also to disseminate findings from the research
supported by the Branch to the public, health care professionals,
scientists engaged in cancer control, and the public health
community. |
|
Host Susceptibility Factors Branch |
|
Elizabeth Gillanders, Ph.D. Branch Chief |
The Host Susceptibility Factors Branch (HSFB) focuses on personal
susceptibility factors such as genetic, epigenetic, immunological
and hormonal biological pathways, and social, cultural, and race/ethnic
factors.
HSFB’s mission is to plan, develop, direct, coordinate,
and evaluate:
- a comprehensive program of epidemiologic research in the etiology
of cancer in human populations related to host (i.e., personal)
susceptibility factors such as genetic, epigenetic, immunological
and hormonal biological pathways; and social, cultural, and race/ethnicity
factors
- a program of epidemiologic research to study differences
in cancer susceptibility and risk in individuals and populations
and the multiple environmental and genetic factors that jointly
contribute to cancer, with the ultimate goal of elucidating the
etiology of cancer
- a program of extramural epidemiologic research
to evaluate the association of and magnitude of cancer risk associated
with biomarkers of host susceptibility such as physiological
status or function
- research resources, infrastructures, and consortia
with a focus on personal susceptibility factors to facilitate
and maximize the scientific potential of cancer epidemiology
research
Its mission also is to disseminate findings from the
research supported by the Branch to the public, health care professionals,
scientists engaged in cancer control, and the public health community. |
|
|
Clinical and Translational Epidemiology Branch |
|
Deborah Winn, Ph.D.
Acting Branch Chief |
The Clinical and Translational Epidemiology Branch (CTEB) focuses
on clinical factors that influence development of cancer among
persons with underlying diseases and conditions; the progression,
recurrence, and mortality from cancer; and new primary cancers.
CTEB’s mission is to plan, develop, direct, coordinate,
and evaluate:
- a comprehensive program of epidemiologic research in human
populations related to clinical factors that influence development
of cancer among persons with underlying diseases and conditions
and progression, recurrence, new primary cancers, and mortality
from cancer among cancer survivors
- a program of epidemiologic research to study differences in
cancer susceptibility and risk in individuals and populations
and the multiple environmental and genetic factors that jointly
contribute to development of cancer among persons with underlying
diseases and conditions and progression, recurrence, new primary
cancers, and mortality from cancer among cancer survivors with
the ultimate goal of elucidating cancer development and progression
among people with these health conditions
- a program of extramural
epidemiologic research to evaluate the association of and magnitude
of cancer risk associated with biomarkers of cancer development
and progression in persons with underlying diseases and cancer
- resources,
infrastructures, and consortia with a focus on cancer development
and progression in persons with underlying diseases and cancer
to facilitate and maximize the scientific potential of cancer
epidemiology research
Its mission also is to disseminate findings from the research
supported by the Branch to the public, health care professionals,
scientists engaged in cancer control, and the public health community. |
|
The populations studied in the grants
in CTEB are primarily patient populations—persons who have
had cancer, have premalignant conditions or certain chronic or genetic
diseases that may predispose to cancer, or have experienced certain
treatments such as immunosuppression after organ transplants that
may predispose to cancer. |
|
|